Lemonade Q2 Revenue Surges 79%, Narrows Losses, Reaffirms Path to Q4 Profitability
LMND sits 57% above its 52-week low of $35.7.
Summary
Lemonade reported Q2 2026 revenue of $294 million (up 79% YoY) and a sharply narrower Adjusted EBITDA loss of $19 million, while reaffirming its expectation of positive Adjusted EBITDA in Q4 2026. Record-low claims handling costs and a favorable reinsurance renewal underscore improving unit economics.
Key Events · Earnings and Guidance · LMND
-
Revenue Jumps 79% to $294M
Q2 revenue reached $294.4 million, driven by 32% growth in In Force Premium to $1.43 billion and higher premium retention from reduced reinsurance cessions.
-
Adjusted EBITDA Loss Narrows 54%
Adjusted EBITDA loss improved to ($18.7) million from ($40.9) million a year ago; management reiterated expectation of first positive Adjusted EBITDA quarter in Q4 2026.
-
Record-Low LAE Ratio at 5%
Claims handling costs fell to 5% of gross earned premium, nearly half the industry average of 9%, reflecting AI and automation gains across all product lines.
-
Reinsurance Renewal Lowers Cession, Adds Cat Protection
Effective July 1, the new program reduces quota share cession to ~18% and provides up to $40 million per-event catastrophe recovery with a $100 million aggregate limit, including named storm coverage.
Analysis · LMND · Finance
A standout quarter saw revenue climb 79% to $294 million and gross profit rise 76% to $113 million, while the Adjusted EBITDA loss shrank 54% to just $19 million. The company reiterated that it expects its first positive Adjusted EBITDA quarter in Q4 2026 — a milestone that would mark a turning point for the insurtech. Underwriting quality continues to improve: the LAE ratio hit a record low 5%, well below the industry average of 9%, reflecting AI-driven efficiency gains. A renewed reinsurance program lowers cession rates and expands catastrophe protection, and a new $250 million synthetic agents facility with Hannover Re at a lower cost of capital will fund future growth. Against a backdrop of recent insider selling and a CFO transition, these results and the maintained profitability timeline provide a strong counter-narrative that the business model is scaling profitably.
At the time of this filing, LMND was trading at $56.09 on NYSE in the Finance sector, with a market capitalization of approximately $4.8B. The 52-week trading range was $35.70 to $99.90. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.